Henrique Serezani Archives

August 11, 2025

Henrique Serezani named director of Vanderbilt Center for Immunobiology

Since its founding in 2015, VCI has served as a hub of research focused on fundamental human immune system regulation.

By Leigh MacMillan

July 25, 2024

New study to explore infection response in diabetes

With a $3 million research grant, Henrique Serezani will investigate how altered metabolism in diabetes affects inflammation and sepsis.

By Paul Govern

C. Henrique Serezani, PhD, right, and colleagues, from left, Amondrea Blackman, Nathan Klopfenstein and Júlia Miranda Ribeiro Bazzano are studying the early events of the inflammatory response to infection.

December 10, 2020

Study details early events of inflammatory response

Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis.

By Leigh MacMillan

November 29, 2018

Parsing diabetic skin infections

Vanderbilt researchers have discovered a role for an inflammatory mediator in diabetic skin infections, suggesting new therapeutic targets for this common complication of diabetes.

By Paul Govern

3d rendering white blood cells with red blood cells

May 9, 2018

Putting the brakes on sepsis

An enzyme called PTEN reduces inflammatory signaling and mortality in sepsis, suggesting it may be a good therapeutic target for this life-threatening complication of infection.